https://www.selleckchem.com/pr....oducts/defactinib.ht
Predisposing factors, e.g. NYHA Class II, Class III/IV, steroid treatment and acute rejection of transplant ( less then 3 months) were associated with high prevalence of depression. Protective factors, e.g. age and higher ejection fraction after transplant of patients were associated with low prevalence of depression. Female sex, single status and number of months since transplant were associated with high prevalence of anxiety. Single status was associated with high prevalence of both adjustment disorder and transplant-related PTSD.
Curtir
Comentario
Compartilhar
